Codexis (CDXS) News Today $2.23 -0.02 (-0.89%) Closing price 04:00 PM EasternExtended Trading$2.26 +0.04 (+1.57%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDXS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS)Millennium Management LLC lowered its stake in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 97.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,931 shares of the biotechnology company's stock after selling 1June 13 at 3:07 AM | marketbeat.comCantor Fitzgerald Forecasts Codexis FY2026 EarningsJune 11 at 2:39 AM | americanbankingnews.comAnalysts Set Expectations for Codexis FY2026 EarningsCodexis, Inc. (NASDAQ:CDXS - Free Report) - Cantor Fitzgerald issued their FY2026 earnings per share estimates for shares of Codexis in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska forecasts that the biotechnology company will post earJune 10 at 9:17 AM | marketbeat.comNuveen Asset Management LLC Has $8.65 Million Stock Holdings in Codexis, Inc. (NASDAQ:CDXS)Nuveen Asset Management LLC lifted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 18.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,812,345 shares of the biotechnology company's stock after purchasing an additional 283,760 shares during tMay 30, 2025 | marketbeat.comCodexis Highlights Advancements in Eco Synthesis Technology for siRNA Manufacturing at TIDES USA ConferenceMay 22, 2025 | quiverquant.comCodexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNAMay 22, 2025 | globenewswire.comCodexis to Participate in Jefferies Global Healthcare ConferenceMay 21, 2025 | globenewswire.comCantor Fitzgerald Lowers Earnings Estimates for CodexisCodexis, Inc. (NASDAQ:CDXS - Free Report) - Research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share (EPS) estimates for shares of Codexis in a report released on Thursday, May 15th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will post eMay 21, 2025 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Shares Sold by Stifel Financial CorpStifel Financial Corp trimmed its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 75.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,673 shares of the biotechnologyMay 18, 2025 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comQ1 2025 Codexis Inc Earnings CallMay 15, 2025 | ca.finance.yahoo.comCodexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with ...May 15, 2025 | gurufocus.comQ1 2025 Codexis Inc Earnings Call TranscriptMay 15, 2025 | gurufocus.comCodexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOsMay 15, 2025 | msn.comCodexis (CDXS) Navigates Q1 Revenue Challenges, Confirms 2025 OutlookMay 14, 2025 | gurufocus.comCodexis, Inc. (CDXS) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comCodexis (CDXS) Projects Financial Stability Until 2026 | CDXS Stock NewsMay 14, 2025 | gurufocus.comCodexis Reports First Quarter 2025 Financial ResultsMay 14, 2025 | globenewswire.comCodexis, Inc. (NASDAQ:CDXS) Shares Bought by Fred Alger Management LLCFred Alger Management LLC lifted its stake in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 137.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 299,143 shares of the biotechnology company's sMay 13, 2025 | marketbeat.com176,748 Shares in Codexis, Inc. (NASDAQ:CDXS) Acquired by Driehaus Capital Management LLCDriehaus Capital Management LLC bought a new stake in Codexis, Inc. (NASDAQ:CDXS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 176,748 shares of the biotechnology companMay 13, 2025 | marketbeat.comCodexis Stock Short Interest Report | NASDAQ:CDXS | BenzingaMay 13, 2025 | benzinga.comCodexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual MeetingMay 7, 2025 | globenewswire.comCodexis to Report First Quarter 2025 Financial Results on May 14April 30, 2025 | globenewswire.comNantahala Capital Management LLC Sells 126,148 Shares of Codexis, Inc. (NASDAQ:CDXS)Nantahala Capital Management LLC reduced its stake in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 4.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,841,660 shares of the biotechnology company's stock after sApril 30, 2025 | marketbeat.comEnvestnet Asset Management Inc. Purchases 110,541 Shares of Codexis, Inc. (NASDAQ:CDXS)Envestnet Asset Management Inc. increased its stake in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 55.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 309,713 shares of the biotechnology company's stock after buying an addApril 30, 2025 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. raised its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 484.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 183,906 shares of the biotechnology company's sApril 30, 2025 | marketbeat.comGeode Capital Management LLC Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS)Geode Capital Management LLC raised its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 12.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,855,514 shares of theApril 26, 2025 | marketbeat.comCodexis (CDXS) Projected to Post Earnings on ThursdayCodexis (NASDAQ:CDXS) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-codexis-inc-stock/)April 26, 2025 | marketbeat.com182,223 Shares in Codexis, Inc. (NASDAQ:CDXS) Acquired by EAM Investors LLCEAM Investors LLC bought a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 182,223 shares of the biotechnology company's stock, valuApril 19, 2025 | marketbeat.comFranklin Resources Inc. Increases Position in Codexis, Inc. (NASDAQ:CDXS)Franklin Resources Inc. boosted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 501.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 177,101 shares of the biotechnology company's stock after purchasing an additional 147,645 shares duriApril 17, 2025 | marketbeat.comVanguard Group Inc. Purchases 311,082 Shares of Codexis, Inc. (NASDAQ:CDXS)Vanguard Group Inc. boosted its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 7.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,463,801 shares of the biotechnology company'sApril 17, 2025 | marketbeat.comCenterBook Partners LP Makes New $4.69 Million Investment in Codexis, Inc. (NASDAQ:CDXS)CenterBook Partners LP purchased a new position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 982,848 shares of the biotechnology company's stock, valued at apApril 11, 2025 | marketbeat.comMajor Investment Alert: Opaleye Management Inc. Boosts Stake in Codexis!April 9, 2025 | tipranks.comCodexis Announces Board Member Retirement in April 2025April 9, 2025 | tipranks.comCodexis Announces Byron Dorgan to Retire from Board of DirectorsApril 9, 2025 | globenewswire.comCodexis Announces Byron Dorgan to Retire from Board of DirectorsApril 9, 2025 | globenewswire.comCodexis shares bought by Opaleye Management for $198,380April 9, 2025 | investing.comCodexis sees significant stock purchase by Opaleye Management, Inc. for $271,788April 3, 2025 | investing.comCodexis appoints new independent board memberApril 2, 2025 | uk.investing.comCodexis appoints new independent board memberApril 2, 2025 | uk.investing.comCodexis stock hits 52-week low at $2.43 amid market challengesApril 2, 2025 | investing.comCodexis Appoints Cynthia Collins to Board of DirectorsMarch 31, 2025 | tipranks.comCodexis, Inc. (NASDAQ:CDXS) Short Interest Up 50.8% in MarchCodexis, Inc. (NASDAQ:CDXS - Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 4,570,000 shares, an increase of 50.8% from the February 28th total of 3,030,000 shares. Based on an average daily trading volume, of 843,500 shares, the short-interest ratio is currently 5.4 days. Currently, 5.7% of the shares of the stock are sold short.March 31, 2025 | marketbeat.comInvestors should buy Codexis following contract news, says Craig-HallumMarch 26, 2025 | markets.businessinsider.comOpaleye Management Inc. Expands Stake in Codexis Inc.March 25, 2025 | gurufocus.comCodexis announces first revenue-generating contract for ECO Synthesis servicesMarch 24, 2025 | markets.businessinsider.comCodexis Shares Rise After Contract for Its Innovation LabMarch 24, 2025 | marketwatch.comCodexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing ServicesMarch 24, 2025 | finance.yahoo.comFY2025 EPS Estimates for Codexis Cut by Cantor FitzgeraldCodexis, Inc. (NASDAQ:CDXS - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Codexis in a report released on Monday, March 10th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will earn ($0.60) peMarch 13, 2025 | marketbeat.comCodexis, Inc. (NASDAQ:CDXS) Stock Holdings Lifted by Telemark Asset Management LLCTelemark Asset Management LLC lifted its holdings in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 11.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,000,000 shares of the biotechnology company's stock after buying an additional 303,589March 13, 2025 | marketbeat.com Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address CDXS Media Mentions By Week CDXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXS News Sentiment▼1.170.88▲Average Medical News Sentiment CDXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXS Articles This Week▼73▲CDXS Articles Average Week Get Codexis News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RGLS News ZBIO News MYGN News RIGL News EBS News VSTM News XOMA News VNDA News LXRX News BOLT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXS) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Codexis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Codexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.